Results 171 to 180 of about 50,334 (225)
Thyroid-stimulating immunoglobulins as a reliable predictive blood test for thyroid eye disease. [PDF]
Indian J OphthalmolMadgar S +9 more
europepmc +1 more source
Redefining evidence for teprotumumab in thyroid eye disease: an updated meta-analysis of efficacy and safety. [PDF]
Front Endocrinol (Lausanne)Song R +7 more
europepmc +1 more source
Sectoral and Layer-Specific Corneal Thinning in Thyroid Eye Disease: A Cross-Sectional Study. [PDF]
Transl Vis Sci TechnolChang YM +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Australasian journal of optometry, The, 2017
Thyroid eye disease is a multifactorial autoimmune disease with a spectrum of signs and symptoms. Oftentimes, the diagnosis of thyroid eye disease is straightforward, based upon history and physical examination. The purpose of this review is to assist the eye-care practitioner in staging the severity of thyroid eye disease (mild, moderate-to-severe and
exaly +3 more sources
Thyroid eye disease is a multifactorial autoimmune disease with a spectrum of signs and symptoms. Oftentimes, the diagnosis of thyroid eye disease is straightforward, based upon history and physical examination. The purpose of this review is to assist the eye-care practitioner in staging the severity of thyroid eye disease (mild, moderate-to-severe and
exaly +3 more sources
BMJ, 2009
Thyroid eye disease is a relatively rare condition, with an incidence of 2.9 to 16.0 cases per 100 000 population per year.1 The disease mainly affects women. Many patients experience distressing symptoms, and a few develop sight threatening complications. Patients are often young or middle aged and at the peak of their career.
Petros, Perros +2 more
openaire +4 more sources
Thyroid eye disease is a relatively rare condition, with an incidence of 2.9 to 16.0 cases per 100 000 population per year.1 The disease mainly affects women. Many patients experience distressing symptoms, and a few develop sight threatening complications. Patients are often young or middle aged and at the peak of their career.
Petros, Perros +2 more
openaire +4 more sources
Seminars in Ophthalmology, 1999
Thyroid eye disease is the most common cause of unilateral and bilateral proptosis in adults. It occurs most frequently in women aged 30 to 50 years. Clinical features include eyelid retraction, periorbital edema, conjunctival injection and chemosis, proptosis, extraocular muscle restriction, exposure keratopathy, and optic nerve compromise.
I U, Scott, M R, Siatkowski
openaire +2 more sources
Thyroid eye disease is the most common cause of unilateral and bilateral proptosis in adults. It occurs most frequently in women aged 30 to 50 years. Clinical features include eyelid retraction, periorbital edema, conjunctival injection and chemosis, proptosis, extraocular muscle restriction, exposure keratopathy, and optic nerve compromise.
I U, Scott, M R, Siatkowski
openaire +2 more sources
Neurologic Clinics, 2010
Thyroid eye disease (TED) is the most common cause of proptosis in adults, and should always be a consideration in patients with unexplained diplopia, pain, or optic nerve dysfunction. At least 80% of TED is associated with Graves disease (GD), and at least 50% of patients with GD develop clinically evident symptomatic TED.
Kimberly P, Cockerham, Stephanie S, Chan
openaire +2 more sources
Thyroid eye disease (TED) is the most common cause of proptosis in adults, and should always be a consideration in patients with unexplained diplopia, pain, or optic nerve dysfunction. At least 80% of TED is associated with Graves disease (GD), and at least 50% of patients with GD develop clinically evident symptomatic TED.
Kimberly P, Cockerham, Stephanie S, Chan
openaire +2 more sources